In contrast, Epas1 is required for anti-tumor responses of adoptively transferred tumor-specific CD8 T cells, as we demonstrated, but not for anti-tumor responses of endogenous CD8 T cells (50). The gene discussed is CD8A; the disease is neoplasm.